Moomoo AI 已提取核心信息
On December 31, 2023, a significant filing was made with the United States Securities and Exchange Commission (SEC) by Sabby Volatility Warrant Master Fund, Ltd., Sabby Management, LLC, and Hal Mintz regarding their collective ownership in Tonix Pharmaceuticals Holding Corp. According to the Schedule 13G document, each of the reporting entities disclosed a shared voting and dispositive power over 5,205,348 shares of Tonix Pharmaceuticals' common stock, which represents 9.99% of the company's class of securities. The entities involved are Sabby Volatility Warrant Master Fund, Ltd., based in the Cayman Islands, Sabby Management, LLC, a Delaware limited liability company, and Hal Mintz, an individual from the USA. Sabby Management, LLC serves as the investment manager of Sabby Volatility Warrant Master Fund, Ltd., and Hal Mintz...Show More
On December 31, 2023, a significant filing was made with the United States Securities and Exchange Commission (SEC) by Sabby Volatility Warrant Master Fund, Ltd., Sabby Management, LLC, and Hal Mintz regarding their collective ownership in Tonix Pharmaceuticals Holding Corp. According to the Schedule 13G document, each of the reporting entities disclosed a shared voting and dispositive power over 5,205,348 shares of Tonix Pharmaceuticals' common stock, which represents 9.99% of the company's class of securities. The entities involved are Sabby Volatility Warrant Master Fund, Ltd., based in the Cayman Islands, Sabby Management, LLC, a Delaware limited liability company, and Hal Mintz, an individual from the USA. Sabby Management, LLC serves as the investment manager of Sabby Volatility Warrant Master Fund, Ltd., and Hal Mintz is the manager of Sabby Management, LLC, which accounts for their indirect ownership of the shares. The filing, dated January 3, 2024, asserts that the shares were not acquired for the purpose of changing or influencing the control of Tonix Pharmaceuticals and were not part of a transaction with such a purpose or effect.
2023年12月31日，萨比波动率权证万事达基金有限公司、Sabby Management, LLC和Hal Mintz就其在Tonix制药控股公司的集体所有权向美国证券交易委员会（SEC）提交了一份重要文件。根据附表13G文件，每个申报实体都披露了对Tonix Pharmaceuticals普通股5,205,348股的共享投票权和处置权，占9.99％ 公司的证券类别。涉及的实体包括总部位于开曼群岛的Sabby波动率权证万事达基金有限公司、特拉华州有限责任公司Sabby Management, LLC和来自美国的个人Hal Mintz。Sabby Management, LLC担任Sabby波...展开全部
2023年12月31日，萨比波动率权证万事达基金有限公司、Sabby Management, LLC和Hal Mintz就其在Tonix制药控股公司的集体所有权向美国证券交易委员会（SEC）提交了一份重要文件。根据附表13G文件，每个申报实体都披露了对Tonix Pharmaceuticals普通股5,205,348股的共享投票权和处置权，占9.99％ 公司的证券类别。涉及的实体包括总部位于开曼群岛的Sabby波动率权证万事达基金有限公司、特拉华州有限责任公司Sabby Management, LLC和来自美国的个人Hal Mintz。Sabby Management, LLC担任Sabby波动率权证万事达基金有限公司的投资经理，哈尔·明茨是Sabby Management, LLC的经理，该公司说明了他们对股票的间接所有权。这份日期为2024年1月3日的文件称，收购这些股票不是为了改变或影响Tonix Pharmicals的控制权，也不是具有这种目的或效果的交易的一部分。
有用
没用